INSMED Inc — Director's Dealing 2022

May 14, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: INSMED Inc (INSM)
CIK: 0001104506
Period of Report: 2022-05-11

Reporting Person: SHAROKY MELVIN MD (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-05-11	Common Stock	A	14645	—	Acquired	242621	Direct
2022-05-11	Common Stock	P	20000	$17.2	Acquired	262621	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1847	Indirect
Common Stock	1184	Indirect

Footnotes

F1: Represents Restricted Stock Units, each representing a contingent right to receive one share of Common Stock. The Restricted Stock Units have a one year cliff vesting period, provided that the director (a) remains a member of the Board on such vesting date, and (b) attends at least 75% of the meetings of the Board which take place between the grant date and the first anniversary of the grant date. Vested shares are delivered within 30 days of the vesting date.

F2: Each Restricted Stock Unit was granted on May 11, 2022, for no consideration.

F3: This is the weighted average sales price representing the shares purchased at prices ranging from $17.14 to $17.25 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares purchased at each price within the price range upon request.

F4: The Reporting Person is the custodian of Melvin Sharoky C/F Sophie C. Wink UTMA/FL.